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ABSTRACT
Primary lung lymphoma is a rare entity accounting for approximately 0.3% of 
all primary neoplasia of the lung and includes diffuse large B-cell lymphoma 
(DLBL) and lymphomatoid granulomatosis (LYG). Considering that clinical 
features may be similar, whereas epidemiology, morphology, and radiological 
features are different, the authors report a case of a middle-aged man 
who presented multiple pulmonary nodules in the lower lobes and ground-
glass opacities scattered bilaterally on computed tomography. Clinically, he 
presented a consumptive syndrome with respiratory failure and pleurisy, 
which progressed until death. The autopsy findings were consistent with 
lymphomatoid granulomatosis (LYG) grade 3/ diffuse large B-cell lymphoma 
(DLBL). The authors call attention to the difficulty of establishing an accurate 
diagnosis, mainly when the demonstration of EBV-infected atypical B-cells 
fails.
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CASE REPORT
A 63-year-old male patient was reportedly well 
until the unintentional 13 kg of weight loss occurred 
over the past 3 months, concomitantly presenting 
dyspnea, dry cough, ventilatory-dependent thoracic 
pain, hiporexia, but no fever. He was admitted to 
a medical facility where a thoracocentesis and a 
pleural biopsy were performed. Pleural fluid was 
an exudate with lymphomononuclear cellularity 
predominance and the histologic examination of the 
pleural biopsy showed inflammatory infiltrate.
Physical examination at admission revealed 
an ill-looking patient, cachectic, pale, tachypneic 
with room air oximetry of 82%. He was afebrile 
and hemodynamic parameters were within normal 
limits. Clubbed fingers were present. Neurological 
and cardiac examinations were normal, and no 
pathologic peripheral adenomegaly was observed. 
Thoracic examination revealed the presence 
of pleural effusion along with diffuse wheezing 
and rales. Cardiac and abdominal examination 
was unremarkable. Blood gas analysis showed 
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AUTOPSY FINDINGS
The ectoscopy revealed a very emaciated 
cadaver with clubbed fingers. At the opening of the 
left thoracic cavity, a huge amount of whitish pleural 
effusion was drained while some fluid was kept 
enclosed within pleural adhesions. A whitish pleural 
thickening extended into the interlobular septa, in 
the lung (Figure 2A). This tissue infiltration involved 
almost the entire thoracic aorta (Figure 2B), 
the parietal pericardium, the mediastinum, and 
the diaphragm to some extent. The lungs were 
congested and heavy, due to marked edema and 
congestion. The left lung weighed 871 g and the 
right lung 975 g (reference value, (RV): 375 g and 
450 g, respectively). The superior lobes showed 
anthracosis and cystic emphysema, which was 
also present and scattered bilaterally through the 
remaining lobes. Pulmonary thromboemboli were 
detected in the segmental and subsegmental 
branches of the left inferior lobe. The right hemithorax 
showed serosanguineous pleural effusion. The 
heart was enlarged, which was mainly due to left 
ventricular wall hypertrophy (heart weight was 400 
g; RV: 276 g). The left ventricular apex exhibited a 
mural thrombus, and atherosclerosis was mild in the 
coronaries, while the aorta was markedly involved 
with calcifications. Pulmonary whitish and firm 
non-necrotic nodules measuring up to 3 cm were 
noted in the right inferior lobe and diaphragmatic 
lung surface; some of them merged with the pleural 
thickening (Figure 3A). Subcarinal anthracotic and 
reactive enlarged lymph nodes were present.
hypoxemia with hypocapnia. Serologies for HIV 
were negative; and Epstein–Barr virus (EBV) and 
cytomegalovirus (CMV) were positive for IgG but 
negative for IgM.
The thoracic computed tomography (CT) 
showed the presence of an infiltrative mass with 
soft-tissue attenuation involving the posterior 
mediastinum, the chest wall and the pleura, which 
was associated with pleural effusion and atelectasis 
of the left lower lobe. The descending aorta and its 
branches were involved by the mass, but neither 
vascular invasion nor bone erosion were observed 
(Figure 1A).
In the right lower and middle lobes, diffuse 
ground-glass opacity and irregular nodules were 
observed (Figure 1B), as well as smaller nodules 
present in the left lung. The upper lobes exhibited 
bullae and pan-lobular emphysema.
The patient was initially prescribed ceftriaxone 
and clarithromycin, non-invasive ventilatory support, 
and physiotherapy. Since the clinical picture did not 
improve, the antibiotics were empirically changed 
to meropenem. Unfortunately, marked impaired 
clinical status prevented further diagnostic work-up. 
Respiratory insufficiency worsened and the patient 
died after 8 days of hospitalization.
Figure 1 – Axial CT of the thorax — A - mediastinum window showing retraction of the base of the left 
hemithorax. Infiltrative homogeneous mass with soft-tissue attenuation involving the chest wall, pleura, and 
posterior mediastinum, can be seen, which is associated with pleural effusion and atelectasis of the left lower 
lobe. Note the involvement of the descending aorta and branches without vascular invasion or bone erosion; 
B - pulmonary window showing multiple solid pulmonary nodules at the right lung base, some of which exhibit 
air bronchogram.
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necrosis. Immunohistochemistry profile of atypical 
large cells was CD20+ (Figure 4A); PAX5+; CD30−. 
The proliferation index, accessed by Ki67, was 
approximately 90%. Small background lymphocytes 
were mostly CD8+ (Figure 4B). EBV was negative by 
both in-situ hybridization, and immunohistochemistry 
gave a negative result. These findings were 
consistent with a pleuropulmonary diffuse large B cell 
lymphoma (DLBL) with some features reminiscent of 
grade 3 lymphomatoid granulomatosis (LYG). The 
The histologic findings of the pulmonary 
nodules (Figure 3B), infiltrative pleural lesion, 
posterior mediastinum, and periaortic involvement 
were characterized by a proliferation of atypical 
B-lymphocytes (Figure 3C), sometimes in a 
sheet-like and angiocentric perivascular pattern 
(Figure 3D). These cells were immersed in a diffuse 
background of numerous small T-lymphocytes, 
histiocytes, and occasional plasma cells, with 
moderate angiocentric behavior but no central 
Figure 2 – A – Gross aspect of the left pleural surface and whitish pleural fluid (bottom). B - “Fish flesh” gross 
aspect of the tumor involving the thoracic aorta.
Figure 3 – A – Gross aspect of the right lung showing sharply circumscribed nodules; B – Photomicrography 
of a nodular lesion (HE, 100X); C – Diffuse aspect of lymphoid proliferation in sheets with inflammatory 
background (HE, 200X); D – Perivascular destructive infiltration (angiocentrism) (HE, 400X).
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than 1% of all cases of non-Hodgkin lymphoma, 
and 3-4% of all the extra nodal manifestations of 
non-Hodgkin lymphomas.3,5,6
The most common PLLs are of B-cell 
lineage and include the marginal zone lymphoma 
(MZL), which is the most common and accounts 
for approximately 70% of cases,7 followed by the 
primary pulmonary DLBL, which accounts for 12-
20% of cases.8-11
Primary DLBL of the lung occurs mostly 
during the sixth or seventh decades of life and 
presents usually symptomatic with dyspnea, cough, 
and severe impairment of the general clinical 
status. Although this lymphoma is more frequently 
associated with HIV infection, it has also been 
identified in non-immunosuppressed patients, which 
does not show any clinical difference with the former. 
A subset of lymphomas arises by transformation of 
pre-existing or concurrent MZL, small lymphocytic 
lymphoma, and follicular lymphoma.12 Boone et al.13 
reported the case of a DLBL following the treatment 
of a grade 3 LYG. A newly recognized subset of 
this lymphoma is the aggressive EBV-DLBL of the 
elderly, which arises in patients older than 50 years, 
(mean age of 72 years, with 25% of cases occurring 
in patients older than 90 years), although rare cases 
have been described in younger patients. In this 
subset of DLBCL, pleural effusions have been noted 
in 9% of cases where atypical cells CD20+ (EBV RNA 
(EBER+)) over CD3+ background cells are evident in 
cell-block preparations.14 Radiological findings of this 
lung lymphoma show that, in general, it constitutes 
a solitary pulmonary mass accompanied by loco 
regional invasion, although ground-glass shadows 
are also reported. Eventually, pleural effusion may 
also be present.15-17
mediastinal and abdominal lymph nodes, spleen, 
liver, and bone marrow were free of neoplasia.
Other pulmonary findings were diffuse 
alveolar damage (acute and organizing), organizing 
pneumonia, interstitial fibrosis, anthracosis, and 
respiratory bronchiolitis. Ferruginous bodies and 
other evidence of asbestos exposure were not 
detected.
Other autopsy findings included acute tubular 
necrosis and signs of systemic hypertension.
DISCUSSION
The lymphoid tissue of the lung is represented 
by sparse submucosal aggregates of small 
lymphocytes, which become more pronounced 
along the bronchioles and central airways and 
the intraparenchymal, septal, and hilar lymph 
nodes.1 Various antigenic stimuli trigger an immune 
response, which leads to lymphoid hyperplasia—
often referred to mucosa-associated lymphoid tissue 
(MALT) or malignant lymphoproliferative disorders.2
Extranodal non-Hodgkin lymphomas have 
been reported to occur in any organ of the body, 
but the lung is one of the most common sites, 
following the gastrointestinal tract, skin, and 
nervous system.3,4 The so-called primary lung 
lymphomas (PLLs) are rare, hence the lungs are 
involved by lymphomas mostly secondarily through 
hematogenous dissemination of Hodgkin or non-
Hodgkin lymphomas, or by contiguous invasion 
from a hilar or mediastinal site.3 PLLs represent only 
0.3% of all primary malignancies of the lung, less 
Figure 4 – Immunohistochemistry (400X) showing diffuse CD20 staining (A), in a background of reactive 
CD8+ T-lymphocytes (B), and histiocytes.
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requirement for LYG diagnosis is the presence of a 
polymorphous background, without which the WHO 
classifies it as a DLBL.26,27 Evidence of EBV infection 
may vary in different biopsy sites of the same case, 
and if the results are negative, they may become 
positive in subsequent biopsies. In the experience of 
Katzenstein et al.,19 staining may be focally positive, 
and some blocks from the same biopsy specimen 
may be EBV-negative; whereas others are positive, 
requiring the testing of multiple blocks to avoid false-
negative results. Diverse opinions remain as if LYG 
constitutes a specific entity due to its histological 
heterogeneity. In this setting, maybe considering 
LYG as an entity with different morphological faces 
could be more accurate.26
Since the Katzenstein et al.28 early study 
in 1979, it was observed that the percentage 
of atypical large B-cells was directly related to 
mortality. Therefore, a grading system from 1 to 3 
was proposed. Nevertheless, grading is not that 
easy; it requires the analysis of multiple slides, once 
the infiltrate appearance varies from area to area on 
the same slide and among different slides. In 2008, 
the WHO27 adopted a grading system based on the 
quantity of large B-cells and the number staining 
for EBV by ISH. However, Katzenstein et al.19 
experience in 2010 suggested that counting the 
number of EBV+ cells may not correlate with the 
grade, but the proportion of large B-cells in the 
infiltrate seemed to be more accurate.
Typical imaging findings include: multiple, 
bilateral, peribronchovascular nodules or masses 
with well- or poorly-defined margins, ranging from 
0.5 cm to 10 cm distributed predominantly in the 
lung bases.2,15,29,30 Internal air-bronchogram can be 
seen,30,31 and the nodule may excavate, disappear, 
or migrate, which is similar to the behavior found in 
polyangiitis with granulomatosis. Solitary nodules, 
alveolar, and reticulonodular opacities may occur, 
but less frequently. Mediastinal lymphadenomegaly 
is found in 25% of cases,15,30,32 and pleural effusions 
have been reported in 33% of cases.28 Ground-
glass opacities accompanied by signs of pulmonary 
fibrosis15 as well as pericardial effusion with 
epicardial mass has already been described.33
Unfortunately, not all cases of LYG present 
all histologic features recommended for diagnosis, 
so they require complementation with clinical and 
radiological data. For this reason Katzenstein et al.19 
proposed an algorithm and the following criteria 
(Table 1).
LYG is a rare pulmonary disease (less than 
3% of all PLLs) with a high mortality rate, which 
was first described by Liebow et al.18 in 1972. They 
questioned whether it was part of an inflammatory 
process or a lymphoproliferative disorder. As time 
passed, LYG was accepted as a lymphoproliferative 
disease, although some other uncertainties still 
remain.
LYG is more common among middle-aged 
adults with a mean age of 48–50 years (range 
40–70 years) with male predominance (male to 
female 2:1). Fever, cough, dyspnea, chest pain, 
malaise, and weight loss are the most common 
presenting complaints.19 Eventually, hemoptysis 
may be present. Clinical features may also reflect a 
multiorgan systemic disease, because, in addition to 
pulmonary involvement, the skin, brain, kidneys, and 
liver may be affected independently or concurrently 
in the late course of illness.2,19
The characteristic histology of LYG is 
represented by nodular replacement of the 
lung parenchyma by a mixed mononuclear cell 
infiltrate composed of small lymphocytes CD3+ 
(and characteristics of cytotoxic T-lymphocytes 
expressing CD8, TIA, and granzyme B),20 large 
lymphocytes CD20+ with atypia, histiocytes, and 
occasional plasma cells. In general, the small 
lymphocytes predominate, but in some cases the 
large atypical cells comprise the main cellular 
component. These large cells may resemble 
immunoblasts with one or two atypical nuclei, often 
congregating in small nests or larger aggregates, and 
frequently around vessel walls. These nodules may 
contain areas of necrosis, which vary from extensive 
central areas to small fibrinoid foci. The intima and 
media are affected, and appear thickened, and 
are associated with luminal narrowing. No vessel 
necrosis is observed. This pattern is described as an 
“angiocentric process,” although the blood vessels 
are secondarily engulfed by the spreading infiltrate, 
which randomly affects lung parenchyma.2,19 The 
possible role of EBV in the pathogenesis of LYG 
was raised in 1990 by Katzenstein and Peiper,21 and 
subsequently confirmed in several studies. Since 
then, the presence of EBV-positive cells by in-situ 
hybridization (ISH) with EBER is now definitional for 
LYG. However, EBV positivity ranges from 57% to 
100% of cases,19,22-25 and by immunohistochemical 
staining for latent protein 1 and EBV nuclear 
antigen 2 in some cases where ISH was positive for 
EBER.19,24 Because of this, in the absence of EBV-
positive cells, the diagnosis should be made with 
caution.26 Beyond the EBV-positive cells, another 
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